PPARGC1A and myeloid sarcoma: The finding of lower mRNA levels in MS than in control IJV walls is compatible with the reduced mRNA expression in peripheral blood mononuclear cells of RR-MS [80] and with reduced expression of PPARGC1A and neuronal loss in MS cortex [81].